Form 4: Dexcom Executive Matthew Dolan Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Matthew Dolan, EVP of Strategy and Corporate at Dexcom Inc., sold 6,710 shares of common stock on March 12, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On March 12, 2024, Matthew Vincent Dolan, EVP of Strategy and Corporate at Dexcom Inc. (DXCM), sold 6,710 shares of Dexcom's common stock.
- The sale was executed at a price of $134.4107 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units (RSUs).
- Following the transaction, Dolan beneficially owns 48,570 shares of Dexcom common stock.
- This number includes 40,075 unvested restricted stock units, which were granted on March 8, 2022, March 8, 2023, and March 8, 2024, and vest through March 8, 2025, March 8, 2026, and March 8, 2027 respectively.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction (stock sale for tax obligations) and doesn't inherently convey positive or negative sentiment about the company's performance.
Industry Context
Executive stock sales are a common occurrence, particularly to cover tax obligations related to equity compensation. The sale itself doesn't necessarily indicate a negative outlook on the company's future prospects.
Stakeholder Impact
- The sale has a minimal impact on shareholders as it is a small percentage of Dolan's holdings and is related to tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/08/2022 | Date of grant for 3,852 unvested restricted stock units, vesting through March 8, 2025. |
| 03/08/2023 | Date of grant for 14,512 unvested restricted stock units, vesting through March 8, 2026. |
| 03/08/2024 | Date of grant for 21,711 unvested restricted stock units, vesting through March 8, 2027. |
| 03/12/2024 | Date of transaction: Matthew Dolan sold 6,710 shares of Dexcom common stock. |
| 03/14/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.